BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 11095660)

  • 1. Effect of mycophenolate mofetil on long-term outcomes in African american renal transplant recipients.
    Meier-Kriesche HU; Ojo AO; Leichtman AB; Punch JD; Hanson JA; Cibrik DM; Kaplan B
    J Am Soc Nephrol; 2000 Dec; 11(12):2366-2370. PubMed ID: 11095660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil reduces the risk of acute rejection less in African-American than in Caucasian kidney recipients.
    Schweitzer EJ; Yoon S; Fink J; Wiland A; Anderson L; Kuo PC; Lim JW; Johnson LB; Farney AC; Weir MR; Bartlett ST
    Transplantation; 1998 Jan; 65(2):242-8. PubMed ID: 9458022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate mofetil vs. azathioprine is associated with decreased acute rejection, late acute rejection, and risk for cardiovascular death in renal transplant recipients with pre-transplant diabetes.
    David KM; Morris JA; Steffen BJ; Chi-Burris KS; Gotz VP; Gordon RD
    Clin Transplant; 2005 Apr; 19(2):279-85. PubMed ID: 15740568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of mycophenolate mofetil and HLA matching on renal allograft survival.
    Meier-Kriesche HU; Ojo AO; Leichtman AB; Magee JC; Rudich SM; Hanson JA; Cibrik DM; Kaplan B
    Transplantation; 2001 Feb; 71(3):398-401. PubMed ID: 11233900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil vs azathioprine in a large population of elderly renal transplant patients.
    Meier-Kriesche HU; Morris JA; Chu AH; Steffen BJ; Gotz VP; Gordon RD; Kaplan B
    Nephrol Dial Transplant; 2004 Nov; 19(11):2864-9. PubMed ID: 15496562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection.
    Ojo AO; Meier-Kriesche HU; Hanson JA; Leichtman AB; Cibrik D; Magee JC; Wolfe RA; Agodoa LY; Kaplan B
    Transplantation; 2000 Jun; 69(11):2405-9. PubMed ID: 10868649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients.
    Wagner M; Earley AK; Webster AC; Schmid CH; Balk EM; Uhlig K
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007746. PubMed ID: 26633102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.
    Pham PT; Pham PC
    Nephrol Dial Transplant; 2012 Jul; 27(7):2965-71. PubMed ID: 22207327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Mycophenolate Mofetil Acute Renal Rejection Study Group
    Transplantation; 2001 Apr; 71(8):1091-7. PubMed ID: 11374408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive therapy in high-risk transplant patients: dose-dependent efficacy of mycophenolate mofetil in African-American renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.
    Neylan JF
    Transplantation; 1997 Nov; 64(9):1277-82. PubMed ID: 9371668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years.
    Ahsan N; Johnson C; Gonwa T; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; VanVeldhuisen P; Salm K; Tolzman D; Fitzsimmons WE
    Transplantation; 2001 Jul; 72(2):245-50. PubMed ID: 11477347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil is associated with less death with function than azathioprine in cadaveric renal transplantation.
    Schnitzler MA; Craig KE; Hardinger KE; Lowell JA; Brennan DC
    Nephrol Dial Transplant; 2003 Jun; 18(6):1197-200. PubMed ID: 12748355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review.
    Knight SR; Russell NK; Barcena L; Morris PJ
    Transplantation; 2009 Mar; 87(6):785-94. PubMed ID: 19300178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes in African American kidney transplant recipients under contemporary immunosuppression: a four-yr analysis of the Mycophenolic acid Observational REnal transplant (MORE) study.
    Narayanan M; Pankewycz O; Shihab F; Wiland A; McCague K; Chan L
    Clin Transplant; 2014 Feb; 28(2):184-91. PubMed ID: 24372743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolate mofetil in cadaveric renal transplantation. US Renal Transplant Mycophenolate Mofetil Study Group.
    Am J Kidney Dis; 1999 Aug; 34(2):296-303. PubMed ID: 10430977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, prospective trial of mycophenolate mofetil versus azathioprine for prevention of acute renal allograft rejection after simultaneous kidney-pancreas transplantation.
    Merion RM; Henry ML; Melzer JS; Sollinger HW; Sutherland DE; Taylor RJ
    Transplantation; 2000 Jul; 70(1):105-11. PubMed ID: 10919583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration.
    Meier-Kriesche HU; Steffen BJ; Hochberg AM; Gordon RD; Liebman MN; Morris JA; Kaplan B
    Transplantation; 2003 Apr; 75(8):1341-6. PubMed ID: 12717227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of a single-center experience with mycophenolate mofetil based immunosuppression in renal transplantation.
    Triemer HL; Pearson TC; Odom KL; Larsen CP
    Clin Transplant; 2000 Aug; 14(4 Pt 2):413-20. PubMed ID: 10946781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.